{
      "brief_title": [
            "safety",
            "tolerability",
            "study",
            "drug",
            "treat",
            "schizophrenia"
      ],
      "brief_summary": [
            "purpose",
            "study",
            "evaluate",
            "safety",
            "patient",
            "schizophrenia"
      ],
      "condition": [
            "schizophrenia"
      ],
      "intervention_type": [
            "drug"
      ],
      "intervention_name": [
            "lurasidone"
      ],
      "description": [
            "lurasidone",
            "oral",
            "tablet",
            "take",
            "daily"
      ],
      "arm_group_label": [
            "lurasidone"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "successful",
            "completion",
            "participation",
            "protocol",
            "exclusion",
            "criterion",
            "substance",
            "abuse",
            "prolactin",
            "level",
            "baseline",
            "pregnancy"
      ],
      "gender": [],
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [
            "65",
            "year"
      ],
      "healthy_volunteers": false,
      "id": "NCT00044005.xml"
}